The Living Guidelines: STEMI
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]
Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.
Pharmacotherapy
Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Beta Blocker Therapy [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for ACE Inhibitors Therapy
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Angiotensin Receptor Blockers Therapy
CLASS I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Aldosterone Blockers Therapy
CLASS I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System
CLASS I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Influenza Vaccination [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Reperfusion
Primary Invasive or Pharmacological Approach [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Facilitated PCI [1]
CLASS IIb
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Immediate (or Emergency) Invasive Strategy and Rescue PCI [1]
Class I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion [1]
Class IIb
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Anticoagulants as Ancillary Therapy [1]
Class I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Anticoagulants for STEMI patients who do not undergo reperfusion therapy [1]
Class IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Thienopyridines [1]
Class I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Reference
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter
|month=
ignored (help)